These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32506380)

  • 41. Whether to target single or multiple CDKs for therapy? That is the question.
    Węsierska-Gądek J; Maurer M; Zulehner N; Komina O
    J Cell Physiol; 2011 Feb; 226(2):341-9. PubMed ID: 20836132
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential changes of CDK activities in glomeruli and tubules during the active DNA synthetic period after ischemic injury.
    Park SK; Kim W; Lee CH; Koh GY
    Nephron; 2000 Nov; 86(3):306-14. PubMed ID: 11096288
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glucocorticoids induce G1 as well as S-phase lengthening in normal human stimulated lymphocytes: differential effects on cell cycle regulatory proteins.
    Baghdassarian N; Catallo R; Mahly MA; Ffrench P; Chizat F; Bryon PA; Ffrench M
    Exp Cell Res; 1998 May; 240(2):263-73. PubMed ID: 9596999
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cell-cycle control and plant development.
    Inagaki S; Umeda M
    Int Rev Cell Mol Biol; 2011; 291():227-61. PubMed ID: 22017978
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CDKs and CKIs: molecular targets for tissue remodelling.
    Nabel EG
    Nat Rev Drug Discov; 2002 Aug; 1(8):587-98. PubMed ID: 12402499
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction of cyclins E and A in response to mitogen removal: a basic alteration associated with the arrest of differentiation of C2 myoblasts transformed by simian virus 40 large T antigen.
    Tedesco D; Baron L; Fischer-Fantuzzi L; Vesco C
    J Virol; 1997 Mar; 71(3):2217-24. PubMed ID: 9032356
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ATP-noncompetitive inhibitors of CDK-cyclin complexes.
    Orzáez M; Gortat A; Mondragón L; Bachs O; Pérez-Payá E
    ChemMedChem; 2009 Jan; 4(1):19-24. PubMed ID: 19039815
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes.
    Flink IL; Oana S; Maitra N; Bahl JJ; Morkin E
    J Mol Cell Cardiol; 1998 Mar; 30(3):563-78. PubMed ID: 9515032
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibiting cyclin-dependent kinase/cyclin activity for the treatment of cancer and cardiovascular disease.
    Ivorra C; Samyn H; Edo MD; Castro C; Sanz-González SM; Déez-Juan A; Andrés V
    Curr Pharm Biotechnol; 2003 Feb; 4(1):21-37. PubMed ID: 12570680
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cyclin/Cdk complexes: their involvement in cell cycle progression and mitotic division.
    John PC; Mews M; Moore R
    Protoplasma; 2001; 216(3-4):119-42. PubMed ID: 11732181
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel functions of plant cyclin-dependent kinase inhibitors, ICK1/KRP1, can act non-cell-autonomously and inhibit entry into mitosis.
    Weinl C; Marquardt S; Kuijt SJ; Nowack MK; Jakoby MJ; Hülskamp M; Schnittger A
    Plant Cell; 2005 Jun; 17(6):1704-22. PubMed ID: 15749764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Regulation of Cyclins and Cyclin-Dependent Kinases in the Development of Gastric Cancer.
    Javed A; Yarmohammadi M; Korkmaz KS; Rubio-Tomás T
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769170
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclin-dependent kinase (cdk) inhibitors/cdk4/cdk2 complexes in early stages of mouse mammary preneoplasia.
    Said TK; Moraes RC; Singh U; Kittrell FS; Medina D
    Cell Growth Differ; 2001 Jun; 12(6):285-95. PubMed ID: 11432803
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CDKs and cyclins in transition(s).
    Fisher RP
    Curr Opin Genet Dev; 1997 Feb; 7(1):32-8. PubMed ID: 9024639
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell cycle regulators during human atrial development.
    Kim WH; Joo CU; Ku JH; Ryu CH; Koh KN; Koh GY; Ko JK
    Korean J Intern Med; 1998 Jul; 13(2):77-82. PubMed ID: 9735660
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of controlled proteolysis in cell-cycle regulation.
    Udvardy A
    Eur J Biochem; 1996 Sep; 240(2):307-13. PubMed ID: 8841392
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monoclonal antibody probes for p21WAF1/CIP1 and the INK4 family of cyclin-dependent kinase inhibitors.
    Thullberg M; Welcker M; Bartkova J; Kjerulff AA; Lukas J; Högberg J; Bartek J
    Hybridoma; 2000 Feb; 19(1):63-72. PubMed ID: 10768842
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of cyclinT/Cdk9 complex in basal and regulated transcription (review).
    Napolitano G; Majello B; Lania L
    Int J Oncol; 2002 Jul; 21(1):171-7. PubMed ID: 12063565
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes.
    Solvason N; Wu WW; Kabra N; Wu X; Lees E; Howard MC
    J Exp Med; 1996 Aug; 184(2):407-17. PubMed ID: 8760794
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selective inhibition of proteins regulating CDK/cyclin complexes: strategy against cancer--a review.
    Sarita Rajender P; Ramasree D; Bhargavi K; Vasavi M; Uma V
    J Recept Signal Transduct Res; 2010 Aug; 30(4):206-13. PubMed ID: 20560705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.